Jeffrey Weber Explains Organ-Specific Side Effects of Checkpoint Inhibitors
Dr. Jeffrey Weber describes the organ-specific side effects that can occur in a patient on checkpoint inhibitors.
Jeffrey Weber, MD, PhD, from NYU Langone Perlmutter Cancer Center explains the different organ-specific side effects that can occur when a patient is on checkpoint inhibitors. These toxicities can progress quickly and to fatal levels; therefore, patients need careful attention.
For example, an increase in pancreas function can present without any symptoms and requires monitoring of the patient’s lab results. Inflammation in the lungs can become pneumonitis, which can become fatal if not caught in time.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
